跳转到主要内容


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

新闻

USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”

USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”

We have supported the Donor Recognition Program (DRP) in the aspect of submitting new or revised proposed monographs for the U. S. Pharmacopeia (USP)-National Formulary (NF). This collaboration between USP and Dr. Reddy’s plays a vital role in improving global public health by developing and ensuring the availability of quality standards worldwide. We worked extensively with USP on several products by providing material and comments on the proposed monographs since 2007 and have thereby become a Gold-level donor. The USP Donor Recognition Event 2024 was recently held in Hyderabad. To commemorate this achievement, USP recognized us with a crystal award for our significant contribution towards “New and modernized monograph submissions”. Our API team contributed 5 new monographs and 2 modernized monographs for the year 2023.

Contact Us

请填写以下表格,我们会尽快与您联系.

给我们发电子邮件: api@drreddys.com | +91 40 49002222

免责声明

本目錄中的任何信息(包括對任何產品或服務的任何引用)均不構成銷售要約,或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是,只要存在此類監管豁免,就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估,並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途,但可用於第 107A 節。